N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
|
|
- CAS-Nr.
- 726169-73-9
- Englisch Name:
- N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
- Synonyma:
- Mocetinostat;MGCD0103;MG0103;CS-1929;Mocetinostat, >=98%;CD0103) Mocetinostat;MGCD0103(Mocetinostat);Mocetinostat (MGCD0103);Mocetinostat, 10 mM in DMSO;Mocetinostat (MGCD0103,MG0103)
- CBNumber:
- CB42484945
- Summenformel:
- C23H20N6O
- Molgewicht:
- 396.44
- MOL-Datei:
- 726169-73-9.mol
|
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Eigenschaften
- Schmelzpunkt:
- >170oC (dec.)
- Dichte
- 1.340±0.06 g/cm3(Predicted)
- storage temp.
- RT
- L?slichkeit
- Soluble in DMSO (up to 25 mg/ml)
- pka
- 13.13±0.70(Predicted)
- Aggregatzustand
- solid
- Farbe
- Off-white
- Stabilit?t:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
- InChI
- InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
- InChIKey
- HRNLUBSXIHFDHP-UHFFFAOYSA-N
- SMILES
- C(NC1=CC=CC=C1N)(=O)C1=CC=C(CNC2=NC=CC(C3=CC=CN=C3)=N2)C=C1
Sicherheit
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Mocetinostat is a multi-targeted histone deacetylase inhibitor used in cancer therapy. Mocetinostat is undergoing clinical trials for the treatment of various cancers including follicular lymphoma, Hodgkin’s lymphoma and acute myelogenous leukemia.
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 188)Lieferanten
726169-73-9()Verwandte Suche:
- MGCD0103(Mocetinostat)
- MG0103
- Mocetinostat (MGCD0103,MG0103)
- N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
- Mocetinostat (MGCD0103)
- N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Mocetinostat (MGCD0103)
- Mocetinostat, >=98%
- N-(2-Aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide
- MGCD0103;MGCD 0103;MGCD-0103;MG0103
- MGCD0103; MGCD 0103; MGCD-0103
- CS-1929
- Benzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-
- N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide USP/EP/BP
- Mocetinostat
- MGCD0103
- Mocetinostat, 10 mM in DMSO
- CD0103) Mocetinostat
- 726169-73-9
- C23H20ON6
- Inhibitor
- Inhibitors
- API